Murine models of inflammatory bowel disease (IBD): Challenges of modeling human disease

Toxicologic Pathology

Volumn 42, Issue 1, 2014, Pages 99-110

  Devoss, Jason ^a   Diehl, Lauri ^a  

^a GENENTECH INC   (United States)

Author keywords

animal models; gastrointestinal system; inflammation.; mouse; preclinical research and development

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; CROHN DISEASE; EXPERIMENTAL MODEL; GENDER; HISTOLOGY; HUMAN; INFLAMMATORY BOWEL DISEASE; MEDICAL RESEARCH; MURINE MODEL; NONHUMAN; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ANIMAL MODELS; GASTROINTESTINAL SYSTEM; INFLAMMATION.; MOUSE; PRECLINICAL RESEARCH AND DEVELOPMENT;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATORY BOWEL DISEASES; MICE; RESEARCH DESIGN;

EID: 84892764249     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623313509729     Document Type: Article

References (106)

1. Abraham C., Cho J. H.. Inflammatory bowel disease. N Engl J Med. 2009 ; 361: 2066-78
2. Amrouche-Mekkioui I., Djerdjouri B.. N-acetylcysteine improves redox status, mitochondrial dysfunction, mucin-depleted crypts and epithelial hyperplasia in dextran sulfate sodium-induced oxidative colitis in mice. Eur J Pharmacol. 2012 ; 691: 209-17
3. Anderson P. Post-transcriptional regulation of tumor necrosis factor alpha production. Ann Rheum Dis. 2000 ; 59: i3-5
4. Aranda R., Sydora B. C., McAllister P. L., Binder S. W., Yang H. Y., Targan S. R., Kronenberg M.. Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients. J Immunol. 1997 ; 158: 3464-73
5. Armaka M., Apostolaki M., Jacques P., Kontoyiannis D. L., Elewaut D., Kollias G.. Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases. J Exp Med. 2008 ; 205: 331-37
6. Arnott I. D., Landers C. J., Nimmo E. J., Drummond H. E., Smith B. K., Targan S. R., Satsangi J.. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am J Gastroenterol. 2004 ; 99: 2376-84
7. Arrowsmith J. Trial watch: Phase II failures: 2008-2010. Nat Rev Drug Discov. 2011 ; 10: 328-29
8. Arrowsmith J. Trial watch: Phase III and submission failures: 2007-2010. Nat Rev Drug Discov. 2011 ; 10: 87
9. Assaa A., Hartman C., Weiss B., Broide E., Rosenbach Y., Zevit N., Bujanover Y., Shamir R.. Long-term outcome of tumor necrosis factor alpha antagonist's treatment in pediatric Crohn's disease. J Crohns Colitis. 2013 ; 7: 369-76
10. Axelsson L. G., Lanstrom E., Goldschmidt T. J., Gronberg A., Bylund-Fellenius A. C.. Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: Effects in CD4(+)-cell depleted, athymic and NK-cell depleted SCID mice. Inflamm Res. 1996 ; 45: 181-91
11. Becker R., Mansfield E.. Companion diagnostics. Clin AdvHematol Oncol. 2010 ; 8: 478-79
12. Begley C. G., Ellis L. M.. Drug development: Raise standards for preclinical cancer research. Nature. 2012 ; 483: 531-33
13. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001 ; 69: 89-95
14. Bouma G., Kaushiva A., Strober W.. Experimental murine colitis is regulated by two genetic loci, including one on chromosome 11 that regulates IL-12 responses. Gastroenterology. 2002 ; 123: 554-65
15. Brinks V., Weinbuch D., Baker M., Dean Y., Stas P., Kostense S., Rup B., Jiskoot W.. Preclinical models used for immunogenicity prediction of therapeutic proteins. Pharm Res. 2013 ; 30: 1719-28
16. Budarf M. L., Labbé C., David G., Rioux J. D. GWA studies: Rewriting the story of IBD. Trends Genet. 2009 ; 25: 137-46
17. Buisson A., Joubert A., Montoriol P. F., Da Ines D., Hordonneau C., Pereira B., Garcier J. M., Bommelaer G., Petitcolin V.. Diffusion-weighted magnetic resonance imaging for detecting and assessing ileal inflammation in Crohn's disease. Aliment Pharmacol Ther. 2013 ; 37: 537-45
18. Cadwell K., Patel K. K., Maloney N. S., Liu T. C., Ng A. C., Storer C. E., Head R. D., Xavier R., Stappenbeck T. S., Virgin H. W.. Virus-plus- susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell. 2010 ; 141: 1135-45
19. Chassaing B., Srinivasan G., Delgado M. A., Young A. N., Gewirtz A. T., Vijay-Kumar M. Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation. PLoS One. 2012 ; 7: e44328
20. Chogle A., Bu H. F., Wang X., Brown J. B., Chou P. M., Tan X. D.. Milk fat globule-EGF factor 8 is a critical protein for healing of dextran sodium sulfate-induced acute colitis in mice. Mol Med. 2011 ; 17: 502-7
21. Cox J. H., Kljavin N. M., Ota N., Leonard J., Roose-Girma M., Diehl L., Ouyang W., Ghilardi N.. Opposing consequences of IL-23 signaling mediated by innate and adaptive cells in chemically induced colitis in mice. Mucosal Immunol. 2012 ; 5: 99-109
22. Cury D. B., Mizsputen S. J., Versolato C., Miiji L. O., Pereira E., Delboni M. A., Schor N., Moss A. C.. Serum calprotectin levels correlate with biochemical and histological markers of disease activity in TNBS colitis. Cell Immunol. 2013 ; 282: 66-70
23. Danese S., Fiocchi C. Ulcerative colitis. N Engl J Med. 2011 ; 365: 1713-25
24. de Castro D. G., Clarke P. A., Al-Lazikani B., Workman P.. Personalized cancer medicine: Molecular diagnostics, predictive biomarkers, and drug resistance. Clin Pharmacol Ther. 2013 ; 93: 252-59
25. D'Haens G., Feagan B., Colombel J. F., Sandborn W. J., Reinisch W., Rutgeerts P., Carbonnel F., Mary J. Y., Danese S., Fedorak R. N., Hanauer S., Lémann M.. Challenges to the design, execution and analysis of randomized controlled trials for inflammatory bowel disease. Gastroenterology. 2012 ; 143: 1461-69
26. Eckburg P. B., Bik E. M., Bernstein C. N., Purdom E., Dethlefsen L., Sargent M., Gill S. R., Nelson K. E., Relman D. A.. Diversity of the human intestinal microbial flora. Science. 2005 ; 308: 1635-38
27. Elinav E., Strowig T., Kau A. L., Henao-Mejia J., Thaiss C. A., Booth C. J., Peaper D. R., Bertin J., Eisenbarth S. C., Gordon J. I., Flavell R. A.. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell. 2011 ; 145: 745-57
28. Farmer R. G., Hawk W. A., Turnbull R. B.. Clinical patterns in Crohn's disease: A statistical study of 615 cases. Gastroenterology. 1975 ; 68: 627-35
29. Fiorucci S., Distrutti E., Mencarelli A., Barbanti M., Palazzini E., Morelli A.. Inhibition of intestinal bacterial translocation with rifaximin modulates lamina propria monocytic cells reactivity and protects against inflammation in a rodent model of colitis. Digestion. 2002 ; 66: 246-56
30. Frank D. N., St. Amand A. L., Feldman R. A., Boedeker E. C., Harpaz N., Pace N. R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci. 2007 ; 104: 13780-85
31. Gollop J. H., Phillips S. F., Melton L. J., Zinsmeister A. R.. Epidemiologic aspects of Crohn's disease: A populaton based study in Olmsted County.. 1988 ; 29: 49-56
32. Goodsaid F.. Challenges of biomarkers in drug discovery and development. Expert Opin Drug Discov. 2012 ; 7: 457-61
33. Guindi M., Riddell R. H.. Indeterminante colitis. J Clin Pathol. 2004 ; 57: 1233-44
34. Hanania N. A., Wenzel S., Rosén K., Hsieh H. J., Mosesova S., Choy D. F., Lal P., Arron J. R., Harris J. M., Busse W.. Exploring the effects of Omalizumab in allergic asthma. An analysis of biomarkers in the EXTRA study. Am J Respir Crit Care Med. 2013 ; 187: 804-11
35. Hans W., Schölmerich J., Gross V., Falk W.. The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice. Eur J Gastroenterol Hepatol. 2000 ; 12: 267-73
36. Herrinton L. J., Liu L., Lafata J. E., Allison J. E., Andrade S. E., Korner E. J., Chan K. A., Platt R., Hiatt D., O'Connor S.. Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings. Inflamm Bowel Dis. 2007 ; 13: 451-61
37. Hirano D., Kudo S.. Usefulness of CD4+CD45RBhigh CD25- cell-transferred SCID mice for preclinical evaluation of drugs for inflammatory bowel disease. J Pharmacol Sci. 2009 ; 110: 169-81
38. Holst I., Kleinschmidt S., Nolte I., Hewicker-Trautwein M.. Expression of inducible nitric oxide, nitrotyrosine and manganese superoxide dismutase in dogs with inflammatory bowel disease. J Comp Pathol. 2012 ; 146: 76
39. Hoshino H., Sugiyama S., Ohara A., Goto H., Tsukamoto Y., Ozawa T.. Mechanism and prevention of chronic colonic inflammation with trinitrobenzene sulfonic acid in rats. Clin Exp Pharmacol Physiol. 1992 ; 19: 717-22
40. Hudcovic T., Stepánková R., Kozákova H., Hrncír T., Tlaskalová-Hogenová H.. Effects of monocolonization with Escherichia coli strains O6K13 and Nissle 1917 on the development of experimentally induced acute and chronic intestinal inflammation in germ-free immunocompetent and immunodeficient mice. Folia Microbiol (Praha). 2007 ; 52: 618-26
41. Hugot J.-P., Chamaillard M., Zouali H., Lesage S., Cézard J. P., Belaiche J., Almer S., Tysk C., O'Morain C. A., Gassull M., Binder V., Finkel Y., Cortot A., Modigliani R., Laurent-Puig P., Gower-Rousseau C., Macry J., Colombel J. F., Sahbatou M., Thomas G.. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001 ; 411: 599-603
42. Ivanov II, Atarashi K., Manel N., Brodie E. L., Shima T., Karaoz U., Wei D., Goldfarb K. C., Santee C. A., Lynch S. V., Tanoue T., Imaoka A., Itoh K., Takeda K., Umesaki Y., Honda K., Littman D. R.. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009 ; 139: 485-98
43. Johansson M.E., Gustafsson J.K., Holmen-Larsson J., Jabbar K.S., Xia L., Xu H., Ghishan F.K., Carvalho F.A., Gewirtz A.T., Sjovall H., Hansson G.C.. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut. (2013) ;:
44. Johansson M. E., Gustafsson J. K., Sjöberg K. E., Petersson J., Holm L., Sjövall H., Hansson G. C. Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model. PLoS One. 2010 ; 5: e12238
45. Jostins L., Ripke S., Weersma R. K., Duerr R. H., McGovern D. P., Hui K. Y., Lee J. C., Schumm L. P., Sharma Y., Anderson C. A., Essers J., Mitrovic M., Ning K., Cleynen I., Theatre E., Spain S. L., Raychaudhuri S., Goyette P., Wei Z., Abraham C., Achkar J. P., Ahmad T., Amininejad L., Ananthakrishnan A. N., Andersen V., Andrews J. M., Baidoo L., Balschun T., Bampton P. A., Bitton A., Boucher G., Brand S., Büning C., Cohain A., Cichon S., D'Amato M., De Jong D., Devaney K. L., Dubinsky M., Edwards C., Ellinghaus D., Ferguson L. R., Franchimont D., Fransen K., Gearry R., Georges M, Gieger C., Glas J., Haritunians T., Hart A., Hawkey C., Hedl M., Hu X., Karlsen T. H., Kupcinskas L., Kugathasan S., Latiano A., Laukens D., Lawrance I. C., Lees C. W., Louis E., Mahy G., Mansfield J., Morgan A. R., Mowat C., Newman W., Palmieri O., Ponsioen C. Y., Potocnik U., Prescott N. J., Regueiro M., Rotter J. I., Russell R. K., Sanderson J. D., Sans M., Satsangi J., Schreiber S., Simms L. A., Sventoraityte J., Targan S. R., Taylor K. D., Tremelling M., Verspaget H. W., De Vos M., Wijmenga C., Wilson D. C., Winkelmann J., Xavier R. J., Zeissig S., Zhang B., Zhang C. K., Zhao H. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012 ; 491: 119-24
46. Kappelman M. D., Rifas-Shiman S. L., Kleinman K., Ollendorf D., Bousvaros A., Grand R. J., Finkelstein J. A.. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007 ; 5: 1424-29
47. Kaser A., Zeissig S., Blumberg R. S.. Inflammatory bowel disease. Annu Rev Immunol. 2010 ; 28: 573-621
48. Keighley M. R. B., Eastwood D., Ambrose N. S., Allan R. N., Burdon D. W.. Incidence and microbiology of abdominal and pelvic abcesses in Crohn's disease. Gastroenterology. 1982 ; 83: 1271-75
49. Kim T. W., Seo J. N., Suh Y. H., Park H. J., Kim J. H., Kim J. Y., Oh K. I.. Involvement of lymphocytes in dextran sulfate sodium-induced experimental colitis. World J Gastroenterol. 2006 ; 12: 302-5
50. Kitajima S., Morimoto M., Sagara E., Shimizu C., Ikeda Y.. Dextran sodium sulfate-induced colitis in germ-free IQI/Jic mice. Exp Anim. 2001 ; 50: 387-95
51. Kong J., Zhang Z., Musch M. W., Ning G., Sun J., Hart J., Bissonnette M., Li Y. C.. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol. 2008 ; 294: G208-16
52. Kontoyiannis D., Boulougouris G., Manoloukos M., Armaka M., Apostolaki M., Pizarro T., Kotlyarov A., Forster I., Flavell R., Gaestel M., Tsichlis P., Cominelli F., Kollias G.. Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease. J Exp Med. 2002 ; 196: 1563-74
53. Kontoyiannis D., Pasparakis M., Pizarro T. T., Cominelli F., Kollias G.. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immunopathologies. Immunity. 1999 ; 10: 387-98
54. Kosiewicz M.M., Nast C.C., Krishnan A., Rivera-Nieves J., Moskaluk C.A., Matsumoto S., Kozaiwa K., Cominelli F.. Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease. The Journal of clinical investigation. (2001) ; 107: 695-702
55. Kozlowski C., Jeet S., Beyer J., Guerrero S., Lesch J., Wang X., Devoss J., Diehl L.. An entirely automated method to score DSS-induced colitis in mice by digital image analysis of pathology slides. Dis Model Mech. 2013 ; 6: 855-65
56. Krieglstein C. F., Cerwinka W. H., Laroux F. S., Salter J. W., Russell J. M., Schuermann G., Grisham M. B., Ross C. R., Granger D. N.. Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: Divergent roles of superoxide and nitric oxide. J Exp Med. 2001 ; 194: 1207-18
57. Laroui H., Ingersoll S. A., Liu H. C., Baker M. T., Ayyadurai S., Charania M. A., Laroui F., Yan Y., Sitaraman S. V., Merlin D.. Dextran sodium sulfate (DSS) induces colitis in mice by forming nano-lipocomplexes with medium-chain-length fatty acids in the colon. PLoS One. 2012 ; 7: e32084
58. Laukoetter M. G., Nava P., Lee W. Y., Severson E. A., Capaldo C. T., Babbin B. A., Williams I. R., Koval M., Peatman E., Campbell J. A., Dermody T. S., Nusrat A., Parkos C. A.. JAM-A regulates permeability and inflammation in the intestine in vivo. J Exp Med. 2007 ; 204: 3067-76
59. Levine A., Griffiths A., Markowitz J., Wilson D. C., Turner D., Russell R. K., Fell J., Ruemmele F. M., Walters T., Sherlock M., Dubinsky M., Hyams J. S.. Pediatric modification of the Montreal classification for inflammatory bowel disease: The Paris classification. Inflamm Bowel Dis. 2011 ; 17: 1314-21
60. Lodes M. J., Cong Y., Elson C. O., Mohamath R., Landers C. J., Targan S. R., Fort M., Hershberg R. M.. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest. 2004 ; 113: 1296-306
61. Loftus C. G., Loftus E. V., Harmsen W. S., Zinsmeister A. R., Tremaine W. J., Melton L. J., Sandborn W. J.. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis. 2007 ; 13: 254-61
62. Maeda K., Okada M., Yao T., Sakurai T., Iida M., Fuchigami T., Yoshinaga K., Imamura K., Okada Y., Sakamoto K.. Intestinal and extraintestinal complications of Crohn's disease: Predictors and cumalative probability of complications. J Gastroenterol. 1994 ; 29: 577-82
63. Mahler Bristol, I. J., Leiter E. H., Workman A. E., Birkenmeier E. H., Elson C. O., Sundberg J. P. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am J Physiol. 1998 ; 274: G544-51
64. Mansfield K. G., Lin K. C., Xia D., Newman J. V., Schauer D.B., MacKey J., Lackner A. A., Carville A.. Enteropathogenic Escherichia coli and ulcerative colitis in Cotton-Top Tamarins (Saguinus oedipus). J Infect Dis. 2001 ; 184: 803-7
65. Matsumoto S., Okabe Y., Setoyama H., Takayama K., Ohtsuka J., Funahashi H., Imaoka A., Okada Y., Umesaki Y.. Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain. Gut. 1998 ; 43: 71-78
66. McNamee E. N., Masterson J. C., Jedlicka P., Collins C. B., Williams I. R., Rivera-Nieves J.. Ectopic lymphoid tissue alters the chemokine gradient, increases lymphocyte retention and exacerbates murine ileitis. Gut. 2013 ; 62: 53-62
67. McNamee E. N., Wermers J. D., Masterson J. C., Collins C. B., Lebsack M. D., Fillon S., Robinson Z. D., Grenawalt J., Lee J. J., Jedlicka P., Furuta G. T., Rivera-Nieves J.. Novel model of TH2-polarized chronic ileitis: The SAMP1 mouse. Inflamm Bowel Dis. 2010 ; 16: 743-52
68. Mehta S. J., Silver A. R., Lindsay J. O.. Review article: Strategies for the management of chronic unremitting ulcerative colitis. Aliment Pharmacol Ther. 2013 ; 38: 77-97
69. Melgar S., Karlsson L., Rehnström E., Karlsson A., Utkovic H., Jansson L., Michaëlsson E.. Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease. Int Immunopharmacol. 2008 ; 8: 836-44
70. Molodecky N. A., Soon I. S., Rabi D. M., Ghali W. A., Ferris M., Chernoff G., Benchimol E. I., Panaccione R., Ghosh S., Barkema H. W., Kaplan G. G.. Increasing incidence and prevelance of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012 ; 142: 46-54
71. Moolenbeek C., Ruitenberg E. J.. The "Swiss roll": A simple technique for histological studies of the rodent intestine. Lab Anim. 1981 ; 15: 57-59
72. Moore M. W., Babu D., Cotter P. D.. Challenges in the codevelopment of companion diagnostics. Pers Med. 2012 ; 9: 485-96
73. Morohoshi Y., Matsuoka K., Chinen H., Kamada N., Sato T., Hisamatsu T., Okamoto S., Inoue N., Takaishi H., Ogata H., Iwao Y., Hibi T.. Inhibition of neutrophil elastase prevents the development of murine dextran sulfate sodium-induced colitis. Journal of gastroenterology. (2006) ; 41: 318-324
74. Myren J., Bouchier I. A., Watkinson G., Softley A., Clamp S. E., de Dombal F. T.. The OMGE multinational inflammatory bowel disease survey 1976-1986. A further report on 3175 cases. Scand J Gastroenterol. 1988 ; 144: 20-23
75. Nagalingam N. A., Lynch S. V.. Role of microbiota in inflammatory bowel diseases. Inflamm Bowel Dis. 2012 ; 18: 968-84
76. Neurath M., Fuss I., Strober W.. TNBS-colitis. Int Rev Immunol. 2000 ; 19: 51-62
77. Norlander B., Gotthard R., Ström M.. Pharmacokinetics of a 5-aminosalicylic acid enteric-coated tablet in patients with Crohn's disease or ulcerative colitis and in healthy volunteers. Aliment Pharmacol Ther. 1990 ; 4: 497-505
78. Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagaki Y., Nakaya R.. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990 ; 98: 694-702
79. Perse M., Cerar A.. Dextran sodium sulphate colitis mouse model: Traps and tricks. J Biomed Biotechnol. 2012 ; 2012: 718617
80. Petersson J., Schreiber O., Hansson G. C., Gendler S. J., Velcich A., Lundberg J. O., Roos S., Holm L., Phillipson M.. Importance and regulation of the colonic mucus barrier in a mouse model of colitis. Am J Physiol Gastrointest Liver Physiol. 2011 ; 300: G327-33
81. Pizarro T. T., Pastorelli L., Bamias G., Garg R. R., Reuter B. K., Mercado J. R., Chieppa M., Arseneau K. O., Ley K., Cominelli F.. SAMP1/YitFc mouse strain: A spontaneous model of Crohn's disease-like ileitis. Inflamm Bowel Dis. 2011 ; 17: 2566-84
82. Prinz F., Schlange T., Asadullah K.. Believe it or not: How much can we rely on published data on potential drug targets?. Nat Rev Drug Discov. 2011 ; 10: 712
83. Ramirez-Carrozzi V., Sambandam A., Luis E., Lin Z., Jeet S., Lesch J., Hackney J., Kim J., Zhou M., Lai J., Modrusan Z., Sai T., Lee W., Xu M., Caplazi P., Diehl L., de Voss J., Balazs M., Gonzalez L., Singh H., Ouyang W., Pappu R.. IL-17C regulates the innate immune function of epithelial cells in an autocrine manner. Nat Immunol. 2011 ; 12: 1159-66
84. Rath H. C., Schultz M., Sartor B. R.. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun. 2001 ; 69: 2277-85
85. Induction of inflammatory bowel disease in immunodeficient mice by depletion of regulatory T cells. Current protocols in immunology / edited by John E. Coligan... [et al.]. (2001) ; Chapter 15 :
86. Sands B. E.. The placebo response rate in irritable bowel syndrome and inflammatory bowel disease. Digestive Dis. 2009 ; 27: 68-75
87. Sands B. E., Abreu M. T., Ferry G. D., Griffiths A. M., Hanauer S. B., Isaacs K. L., Lewis J. D., Sandborn W. J., Steinhart A. H.. Design issues and outcomes in IBD clinical trials. Inflamm Bowel Dis. 2005 ; 11: S22 - S28
88. Induction of TNBS colitis in mice. Current protocols in immunology / edited by John E. Coligan... [et al.]. (2002) ; Chapter 15 :
89. Scholmerich J., Warren B Inflammatory Bowel Diseases. Satsangi J. Sutherland L. R., ed. England: Churchill Livingstone ; 2003 :
90. Solem C. A., Loftus E. V., Fletcher J. G., Baron T. H., Gostout C. J., Petersen B. T., Tremaine W. J., Egan L. J., Faubion W. A., Schroeder K. W., Pardi D. S., Hanson K. A., Jewell D. A., Barlow J. M., Fidler J. L., Huprich J. E., Johnson C. D., Harmsen W. S., Zinsmeister A. R., Sandborn W. J.. Small-bowel imaging in Crohn's disease: A prospective, blinded, 4-way comparison trial. Gastrointest Endosc. 2008 ; 68: 255-66
91. Stepankova R., Powrie F., Kofronova O., Kozakova H., Hudcovic T., Hrncir T., Uhlig H., Read S., Rehakova Z., Benada O., Heczko P., Strus M., Bland P., Tlaskalova-Hogenova H.. Segmented filamentous bacteria in a defined bacterial cocktail induce intestinal inflammation in SCID mice reconstituted with CD45RBhigh CD4+ T cells. Inflamm Bowel Dis. 2007 ; 13: 1202-11
92. Stevceva L., Pavli P., Husband A.J., Doe W.F.. The inflammatory infiltrate in the acute stage of the dextran sulphate sodium induced colitis: B cell response differs depending on the percentage of DSS used to induce it. BMC clinical pathology. (2001) ; 1 ( 3 ):
93. Strimbu K., Travel J. A.. What are biomarkers. Curr Opin HIV AIDS. 2010 ; 5: 463-66
94. Su C., Lichtenstein G. R., Krok K., Brensinger C. M., Lewis J. D.. A meta-analysis of placebo rates of remission and response in clinical trials of active Crohn's disease. Gastroenterology. 2004 ; 126: 1257-69
95. Targan S. R., Landers C. J., Yang H., Lodes M. J., Cong Y., Papadakis K. A., Vasiliauskas E., Elson C. O., Hershberg R. M.. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology. 2005 ; 128: 2020-28
96. Thway T. M., Magana I., Bautista A., Jawa V., Gu W., Ma M.. Impact of anti-drug antibodies in preclinical pharmacokinetic assessment. AAPS J. 2013 ; 15: 856-63
97. Ukena S. N., Singh A., Westendorf A. M.. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS One. 2007 ; 2: e1308
98. Voltaire (1772). La Begueule, Conte Moral. Reprinted by Kessinger Publishing, LLC (2010), ISBN-10: 1166141098.
99. Vong L. B., Tomita T., Yoshitomi T., Matsui H., Nagasaki Y.. An orally administered redox nanoparticle that accumulates in the colonic mucosa and reduces colitis in mice. Gastroenterology. 2012 ; 143: 1027-36
100. Wadie W., Abdel-Aziz H., Zaki H. F., Kelber O., Weiser D., Khayyal M. T.. STW 5 is effective in dextran sulfate sodium-induced colitis in rats. Int J Colorectal Dis. 2012 ; 27: 1445-53
101. Walker A. W., Sanderson J. D., Churcher C., Parkes G. C., Hudspith B. N., Rayment N., Brostoff J., Parkhill1 J., Dougan G., Petrovska L.. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiology. 2011 ; 11: 7
102. Williams C. S., Bradley A. M., Chaturvedi R., Singh K., Piazuelo M. B., Chen X., McDonough E. M., Schwartz D. A., Brown C. T., Allaman M. M., Coburn L. A., Horst S. N., Beaulieu D. B., Choksi Y. A., Washington M. K., Williams A. D., Fisher M. A., Zinkel S. S., Peek R. M., Wilson K. T., Hiebert S. W.. MTG16 contributes to colonic epithelial integrity in experimental colitis. Gut. 2012 ; 62: 1446-55
103. Xavier R. J., Podolsky D. K.. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007 ; 448: 427-34
104. Yang L. S., Alex G., Catto-Smith A. G.. The use of biologic agents in pediatric inflammatory bowel disease. Curr Opin Pediatr. 2012 ; 24: 609-14
105. Yasukawa K., Tokuda H., Tun X., Utsumi H., Yamada K.. The detrimental effect of nitric oxide on tissue is associated with inflammatory events in the vascular endothelium and neutrophils in mice with dextran sodium sulfate-induced colitis. Free Radic Res. 2012 ; 46: 1427-36
106. Zhernakova A., van Diemen C. C., Wijmenga C.. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet. 2009 ; 10: 43-55